Patients' preference for olanzapine orodispersible tablet compared with conventional oral tablet in a multinational, randomized, crossover study

Long-Term Antipsychotic Monotherapy for Schizophrenia

(2009) Martin Dossenbach et al.   JOURNAL OF CLINICAL PSYCHIATRY

A Meta-Analysis of Head-to-Head Comparisons of Second-Generation Antipsychotics in the Treatment of Schizophrenia

(2008) Stefan Leucht et al.   AMERICAN JOURNAL OF PSYCHIATRY

Olanzapine Orally Disintegrating Tablet: A Review of Efficacy and Compliance

(2008) Luis San et al.   CNS Neuroscience & Therapeutics

Orally disintegrating olanzapine and potential differences in treatment-emergent weight gain

(2008) Jamie Karagianis et al.   HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL

Depot and oral antipsychotics: patient preferences and attitudes are not the same thing

(2008) MX Patel et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial

(2008) René S Kahn et al.   LANCET

Cross-sectional and Longitudinal Relationships Between Insight and Attitudes Toward Medication and Clinical Outcomes in Chronic Schizophrenia

(2008) S. Mohamed et al.   SCHIZOPHRENIA BULLETIN

Ebastine fast-dissolving tablets versus regular tablets: acceptability and preference in patients with allergic rhinitis

(2008) A Roger et al.   Expert Review of Clinical Pharmacology

Antipsychotic prescription patterns in outpatient settings: 24-month results from the Intercontinental Schizophrenia Outpatient Health Outcomes (IC-SOHO) study

(2007) Istvan Bitter et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY